Zacks Research Issues Optimistic Outlook for Clorox Earnings

The Clorox Company (NYSE:CLX - Free Report) - Equities researchers at Zacks Research increased their Q4 2025 earnings per share estimates for shares of Clorox in a research report issued on Monday, May 19th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $2.23 for the quarter, up from their prior estimate of $2.14. The consensus estimate for Clorox's current full-year earnings is $7.15 per share. Zacks Research also issued estimates for Clorox's Q1 2026 earnings at $1.52 EPS, Q2 2026 earnings at $1.51 EPS, Q3 2026 earnings at $1.57 EPS, FY2026 earnings at $6.71 EPS, Q1 2027 earnings at $1.62 EPS, Q2 2027 earnings at $1.71 EPS and Q3 2027 earnings at $1.70 EPS.

Several other equities research analysts also recently commented on the stock. UBS Group reduced their target price on shares of Clorox from $176.00 to $154.00 and set a "neutral" rating on the stock in a research note on Thursday, April 17th. Evercore ISI set a $140.00 price target on Clorox and gave the stock an "underperform" rating in a research report on Tuesday, May 6th. Citigroup cut their price objective on Clorox from $165.00 to $150.00 and set a "neutral" rating for the company in a research report on Monday, April 14th. JPMorgan Chase & Co. lowered their target price on Clorox from $151.00 to $144.00 and set a "neutral" rating for the company in a research note on Tuesday, May 6th. Finally, Royal Bank of Canada restated a "sector perform" rating and issued a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. Three analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and an average target price of $151.23.

Clorox Price Performance

Clorox stock opened at $135.53 on Wednesday. The business has a 50 day simple moving average of $140.57 and a 200 day simple moving average of $152.97. Clorox has a one year low of $127.60 and a one year high of $171.37. The company has a market capitalization of $16.70 billion, a PE ratio of 37.03, a price-to-earnings-growth ratio of 2.62 and a beta of 0.60. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. Clorox had a net margin of 6.38% and a return on equity of 316.87%. The company's quarterly revenue was down 8.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.71 EPS.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in CLX. Brooklyn Investment Group lifted its holdings in Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after purchasing an additional 95 shares during the last quarter. Redwood Park Advisors LLC acquired a new stake in shares of Clorox during the 4th quarter worth about $26,000. Millstone Evans Group LLC bought a new stake in shares of Clorox during the 4th quarter worth about $31,000. Wood Tarver Financial Group LLC bought a new stake in shares of Clorox during the 4th quarter worth about $31,000. Finally, Asset Planning Inc bought a new position in Clorox in the 4th quarter valued at about $32,000. 78.53% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Clorox news, Director Pierre R. Breber acquired 4,000 shares of the company's stock in a transaction on Wednesday, May 7th. The shares were purchased at an average price of $136.57 per share, for a total transaction of $546,280.00. Following the completion of the purchase, the director now directly owns 4,000 shares of the company's stock, valued at approximately $546,280. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.57% of the stock is currently owned by corporate insiders.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, May 9th. Investors of record on Wednesday, April 23rd were given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.60%. The ex-dividend date of this dividend was Wednesday, April 23rd. Clorox's dividend payout ratio is currently 87.61%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.